InvestorsHub on MSN
Roche receives FDA clearance for cobas BV/CV assay, expanding women’s health diagnostics
The new molecular test broadens Roche’s sexual-health diagnostics portfolio by enabling simultaneous detection of bacterial ...
The global food safety testing market is projected to grow from $28.1 billion in 2026 to $52.9 billion by 2034, driving ...
As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, Roche will showcase integrated diagnostic solutions designed to expand access to high-precision testing, ...
Eliminating unnecessary PCR cleanup and normalization steps helps genomics laboratories reduce consumable waste and ...
ALPCO, a distributor of immunoassay-based products and part of NuvinkaDx announces H. pylori Stool Antigen and Lactoferrin assays have received Health Canada licenses, expanding the company’s menu of ...
Seegene, a global molecular diagnostics company, announced Tuesday that its US subsidiary Seegene USA has received emergency ...
Seegene, Inc. ("Seegene"), a global leader in molecular diagnostics, announced today that its U.S. subsidiary, Seegene USA, Inc. ("Seegene USA"), has received an Emergency Use Authorization (EUA) from ...
EUA marks the first U.S. multiplex PCR capable of differential detection of HSV-1, HSV-2, VZV, and MPXV from a single specimen. Overlapping lesion morphology makes sequential single-pathogen testing ...
VIVO explains how ddPCR and NGS support viral surveillance in antiviral trials, from detection and quantification to ...
aInstitute for Biometrics and Epidemiology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany bGerman Center for Diabetes ...
Recent advances in AI may herald the near arrival of systems that can automate essentially all work. We review the macroeconomic implications of this scenario, in a framework synthesizing several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results